These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 19004191)
1. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191 [TBL] [Abstract][Full Text] [Related]
2. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX Kidney Int; 2005 Jun; 67(6):2295-304. PubMed ID: 15882271 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of arterial calcification: spotlight on the inhibitors. Weissen-Plenz G; Nitschke Y; Rutsch F Adv Clin Chem; 2008; 46():263-93. PubMed ID: 19004192 [TBL] [Abstract][Full Text] [Related]
4. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323 [TBL] [Abstract][Full Text] [Related]
5. Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Ketteler M; Vermeer C; Wanner C; Westenfeld R; Jahnen-Dechent W; Floege J Blood Purif; 2002; 20(5):473-6. PubMed ID: 12207096 [TBL] [Abstract][Full Text] [Related]
6. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. El-Abbadi M; Giachelli CM Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):519-24. PubMed ID: 16205469 [TBL] [Abstract][Full Text] [Related]
7. [The bone-vasculature-axis interaction: new insights into the pathogenesis of vascular calcification.]. Cozzolino M; Galassi A; Bellasi A; Gallieni M; Brancaccio D G Ital Nefrol; 2007; 24(5):409-14. PubMed ID: 17886210 [TBL] [Abstract][Full Text] [Related]
8. Vascular calcification in chronic kidney disease. Jono S; Shioi A; Ikari Y; Nishizawa Y J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129 [TBL] [Abstract][Full Text] [Related]
9. "Missing" inhibitors of calcification: general aspects and implications in renal failure. Ketteler M; Westenfeld R; Schlieper G; Brandenburg V; Floege J Pediatr Nephrol; 2005 Mar; 20(3):383-8. PubMed ID: 15549415 [TBL] [Abstract][Full Text] [Related]
10. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207 [TBL] [Abstract][Full Text] [Related]
11. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. Schafer C; Heiss A; Schwarz A; Westenfeld R; Ketteler M; Floege J; Muller-Esterl W; Schinke T; Jahnen-Dechent W J Clin Invest; 2003 Aug; 112(3):357-66. PubMed ID: 12897203 [TBL] [Abstract][Full Text] [Related]
12. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283 [TBL] [Abstract][Full Text] [Related]
13. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry. Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392 [TBL] [Abstract][Full Text] [Related]
14. Fetuin-A and extraosseous calcification in uremia. Ketteler M Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):337-42. PubMed ID: 15931001 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers of vascular calcification and mortality in patients with ESRD. Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076 [TBL] [Abstract][Full Text] [Related]
17. Circulating calcification inhibitors and vascular properties in children after renal transplantation. van Summeren MJ; Hameleers JM; Schurgers LJ; Hoeks AP; Uiterwaal CS; Krüger T; Vermeer C; Kuis W; Lilien MR Pediatr Nephrol; 2008 Jun; 23(6):985-93. PubMed ID: 18286307 [TBL] [Abstract][Full Text] [Related]
18. Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease? Axelsson J; Wang X; Ketteler M; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Nordfors L; Stenvinkel P Am J Nephrol; 2008; 28(4):669-76. PubMed ID: 18337634 [TBL] [Abstract][Full Text] [Related]
19. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients. Cozzolino M; Biondi ML; Galassi A; Gallieni M; d'Eril GV; Brancaccio D Am J Nephrol; 2007; 27(6):639-42. PubMed ID: 17851232 [TBL] [Abstract][Full Text] [Related]
20. [Vascular calcification: mutual interaction between bone and blood vessel]. Yamaguchi A; Akashi T Clin Calcium; 2010 Nov; 20(11):1669-76. PubMed ID: 21037387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]